Home · Peptides · Apelin-12
THE PEPTIDE APP FIELD GUIDE · Metabolic SERIES FIELD SPECIMEN
Metabolic CATEGORY

Apelin-12

THE HEART OPTIMIZER

Pyr¹-Apelin-13 (short isoform), Apelin fragment 12

Apelin-12 is a naturally occurring peptide that acts as a powerful cardiovascular regulator. It improves blood flow, strengthens heart contractions, and enhances how your body processes glucose, all without increasing oxygen demand on the heart. It's being studied for heart failure, metabolic syndrome, and as an anti-aging compound.

Apelin-12
Apelin-12
Apelin-12

Apelin-12 Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

Aug 28, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Apelin-12

◆

Is Apelin-12 FDA approved?

No. This profile records Apelin-12 as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Apelin-12?

Dose: 0.5-1 mg weekly (fractionated doses).

MORE CONTEXT ›

Schedule: daily. Cycle: Ongoing or as needed. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Apelin-12 guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Heart Strengthener

Increases cardiac output without raising oxygen demand

Vasodilation

Relaxes blood vessels for improved circulation

Glucose Uptake

Enhances how cells absorb and use glucose

Anti-Oxidant

Reduces inflammation and oxidative damage in blood vessels

People with cardiovascular concerns
Those wanting to improve metabolic flexibility
Aging individuals focused on heart health
Athletes seeking improved endurance
Anyone with poor circulation

Apelin-12 Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.